Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement
about
Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement
description
scientific article published on 25 November 2017
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2017
@uk
name
Targeted and global pharmacome ...... cholines with dose requirement
@en
Targeted and global pharmacome ...... cholines with dose requirement
@nl
type
label
Targeted and global pharmacome ...... cholines with dose requirement
@en
Targeted and global pharmacome ...... cholines with dose requirement
@nl
prefLabel
Targeted and global pharmacome ...... cholines with dose requirement
@en
Targeted and global pharmacome ...... cholines with dose requirement
@nl
P2093
P1433
P1476
Targeted and global pharmacome ...... cholines with dose requirement
@en
P2093
Alexander B Leichtle
Carlo R Largiadèr
Johanna Sistonen
Lars Englberger
Martin Fiedler
Paul Mohacsi
Uwe Christians
Vilborg Sigurdardottir
P2888
P356
10.1007/S11306-017-1294-8
P577
2017-11-25T00:00:00Z